Sernova Receives Authorization to Enroll Second Patient Cohort of Phase 1/2 Trial with Cell Pouch System™ for Type 1 Diabetes
November 03, 2022 07:30 ET
|
Sernova Corp.
Sernova plans to begin enrollment of second cohort in the coming weeks and implant multiple patients with the enhanced capacity 10-channel Cell Pouch before the end of 2022Positive interim results...
Sernova to Participate in the Roth Inaugural Healthcare Opportunities Conference
September 28, 2022 07:30 ET
|
Sernova Corp.
LONDON, Ontario, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in regenerative cell therapeutics, today announced it...
Sernova Announces Full Exercise of Share Purchase Warrants Expiring September 22, 2022
September 22, 2022 07:30 ET
|
Sernova Corp.
LONDON, Ontario, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE / XETRA:PSH), a clinical-stage company and leader in regenerative cell therapeutics, today announced...
Sernova to Present at H.C. Wainwright Annual Global Investment Conference and LifeSci Partners HealthTech Symposium
September 08, 2022 07:30 ET
|
Sernova Corp.
LONDON, Ontario, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in regenerative medicine cell therapeutics, today...
Sernova Announces the Appointment of Daniel Mahony, Ph.D. to its Board of Directors
September 07, 2022 07:30 ET
|
Sernova Corp.
- Successful biopharma entrepreneur with 25 years of experience growing leading healthcare firms - LONDON, Ontario, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF)...
Sernova Receives Second Tranche Equity Investment from Evotec of $6.8 Million at a Price of $2.50 Per Share
September 01, 2022 07:33 ET
|
Sernova Corp.
LONDON, Ontario, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/ XETRA:PSH), a clinical-stage company and leader in regenerative medicine cell therapeutics, today...
Sernova to Participate in Live Investor Event Hosted by Leede Jones Gable, Inc.
August 30, 2022 07:00 ET
|
Sernova Corp.
LONDON, Ontario, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in regenerative medicine cell therapeutics, today...
Sernova to Participate in the Truist Securities Cell Therapy Symposium, Symposia-cel in June
June 15, 2022 07:00 ET
|
Sernova Corp.
LONDON, Ontario, June 15, 2022 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in regenerative medicine cell therapeutics, today...
Sernova Announces Positive Updated Phase 1/2 Clinical Data on Cell Pouch System™ at American Diabetes Association 82nd Scientific Sessions 2022
June 06, 2022 16:30 ET
|
Sernova Corp.
Researchers from the Dr. Piotr Witkowski Laboratory at the University of Chicago presented updated data on six patients with type 1 diabetes and hypoglycemia unawarenessThe first three patients have...
Sernova and Evotec Enter into an Exclusive Global Strategic Partnership for iPSC-Based Beta Cell Replacement Therapy to Develop and Commercialize a ‘Functional Cure’ for Diabetes
May 17, 2022 07:00 ET
|
Sernova Corp.
Partnership Leverages Sernova’s Proprietary Cell Pouch System™ with Evotec’s iPSC-Based Insulin-Producing Beta CellsPartners to Develop and Commercialize an Off-The-Shelf Cell Replacement Therapy for...